Difficulty: Medium
Average Score: 88%
Practice
Which of the following statements CORRECTLY describes the mechanism of action of imatinib mesylate in chronic myeloid leukemia:
Correct answer
A
Rationale
Imatinib inhibits BCR-ABL tyrosine kinase in CML.